In mammals, nicotinamide (Nam) is biosynthesized from L-tryptophan (L-Trp). The enzymes involved in the initial step of the L-Trp/Nam pathway are L-Trp-2,3-dioxygenase (TDO) and indoleamine-2,3-dioxygenase (IDO). We aimed to determine whether tdo-knockout (tdo 2/2 ) mice fed a diet without preformed niacin can synthesize enough Nam to sustain optimum growth. Wild-type (WT) and tdo 2/2 mice were fed a chemically defined 20% casein diet with or without preformed niacin (30 mg nicotinic acid/kg) for 28 d. Body weight, food intake, and liver NAD concentrations did not differ among the groups. In the groups of mice fed the niacin-free diet, urinary concentrations of the upstream metabolites kynurenine (320% increase, P < 0.0001), kynurenic acid (270% increase, P < 0.0001), xanthurenic acid (770% increase, P < 0.0001), and 3-hydroxyanthranilic acid (3-HA;
Introduction
There have been many studies on the L-tryptophan (L-Trp) to nicotinamide (Nam) 7 pathway that have indicated this pathway plays an important role in the supply of the niacin vitamin. Generally, 60 mg of L-Trp is estimated to be equivalent to 1 mg of Nam in humans (1) (2) (3) (4) (5) (6) (7) (8) . The amount of de novo synthesized Nam from L-Trp is almost equal to the intake of preformed niacin in the Japanese population (9) . Feeding rodents with a niacin-free diet did not have any effects on the endogenous production of Nam from L-Trp (10, 11) . We recently reported that niacin-deficient mice can be generated by quinolinic acid (QA) phosphoribosyltransferase (QPRT) knockout mice (12) . Both L-Trp-2,3-dioxygenase (TDO) and indoleamine-2,3-dioxygenase (IDO) catalyze the oxidative cleavage of L-Trp to N-formylkynurenine, the first step in the L-Trp/kynurenine-/acetyl CoA and L-Trp/kynurenine/Nam pathways. TDO operates mainly in the liver (13) , whereas IDO is ubiquitously distributed in extrahepatic tissues such as the lung (14) , small intestine (15) , and brain (16, 17) and in cells such as macrophages (18) and dendritic cells (19) . IDO2, another enzyme with IDO-like activity, was recently discovered (20, 21) and the tissue and cell distribution has been described (22) . However, the tissue distribution of subsequent enzymes involved in the L-Trp/ kynurenine/acetyl CoA and L-Trp/kynurenine/Nam pathways has not been well studied. It is thought that all enzymes * To whom correspondence should be addressed. E-mail: kshibata@shc.usp.ac.jp. 7 Abbreviations used: KA, kynurenic acid; KAT, kynurenine aminotransferase; MNA, N 1 -methylnicotinamide; IDO, indoleamine-2,3-dioxygenase; Nam, nicotinamide; NaMN, nicotinic acid mononucleotide; NiA, nicotinic acid; QA, quinolinic acid; QPRT, quinolinic acid phosphoribosyltransferase; TDO, L-tryptophan-2,3-dioxygenase; tdo involved in these metabolic pathways exist only in the liver. Therefore, TDO is thought to have a very important role in the L-Trp/kynurenine/Nam pathway. Kanai et al. (23) has reported that in tdo-knockout (tdo 2/2 ) mice, elevated plasma L-Trp and serotonin concentrations were observed. These findings predicted that the conversion activity of L-Trp/Nam in tdo 2/2 mice may be very low compared with wild-type (WT) mice. In the present study using tdo 2/2 mice, we investigated the role of IDO in the L-Trp/kynurenine/Nam pathway.
Methods
The care and treatment of the experimental animals conformed with the guidelines for the ethical treatment of laboratory animals set by the University of Shiga Prefecture (Shiga, Japan). The room temperature was 20°C and the humidity was 60%. A 12-h-light/-dark cycle was maintained.
Expt. 1 Animals and diet. The establishment of tdo 2/2 mice and breeding conditions was previously described (23) . All the mice used in the experiments had the C57BL/6 genetic background through backcrossing for at least 7 generations. Four-week-old tdo 2/2 and WT mice, which were the offspring from the breeding of Tdo heterozygote (tdo +/2 ) mice, were used in the study.
These mice were randomized to receive a chemically defined 20% casein diet [2.3 g L-Trp/kg diet and 30 mg nicotinic acid (NiA)/kg of diet (complete diet)] (12) or an NiA-free diet [2.3 g L-Trp/kg diet (NiA-free diet)] (12) (3 male and 3 female mice per dietary group for each genotype). As previously reported (12) , the chemically defined NiA-free diet elicited niacin deficiency when fed to the QA phosphoribosyltransferase (qprt) gene knockout mice. The tdo 2/2 and WT mice were kept in individual metabolic cages (CL-0355; Clea Japan) and had ad libitum access to food and water for 28 d. Body weight and food intake were measured every day at 0900 h. On the last day of the experiment, urine samples (24 h; 0900-0900 h) were collected in amber bottles. One portion of the urine samples was stored at 220°C for QA measurement. Another portion was treated with 10% (v:v) of 1 mol/L HCl to measure the metabolites of the L-Trp/kynurenine/Nam pathway and were stored at 220°C. After the urine samples were collected, the mice were killed at 0900 h by vertebral subluxation. To measure TDO activity and L-Trp, NAD, and Nam concentrations, the livers were removed and some of them were immediately treated for analysis. Blood was collected for measurement of L-Trp, NAD, and Nam.
TDO activity assay. Livers were removed from the mice, immediately put into 5 volumes of cold 50 mmol/L KH 2 PO 4 -K 2 HPO 4 buffer (pH 7.0), and homogenized using a Teflon glass homogenizer. These homogenates were centrifuged at 15,000 3 g for 30 min at 4°C and the supernatants were used for the assay. The assay was performed as previously described (24) .
L-Trp assay. The amount of the free form of L-Trp in the liver, blood, and urine was measured following the method used by Shibata et al. (25) . The procedures for extracting L-Trp from the liver, blood, and urine and quantifying it by HPLC were previously reported (25) .
Nam assay. The total amounts of Nam, NAD, and NADP in the liver and blood were measured following the method used by Shibata (26) . Nam, NAD, and NADP extraction from the blood and liver, and the method for converting NAD and NADP to Nam, followed by Nam quantification by HPLC were performed as previously reported (26) .
NAD (NAD + + NADH) assay. The amount of NAD (NAD + and NADH) in the blood and tissue was measured following the method used by Shibata and Murata (27) . Livers were removed from the mice and immediately placed into 20 volumes of cold 50 mmol/L KH 2 PO 4 -K 2 HPO 4 buffer (containing 0.1 mol/L Nam, pH 6.0) and homogenized using a Teflon glass homogenizer. The homogenates were placed into 5 volumes of the buffer. Ten microliters of whole blood was added to 200 mL cold buffer. These liver and blood samples were immersed in a hot water bath at 90°C for 90 s. After cooling on ice for 5 min, they were centrifuged at 10,000 3 g for 10 min at 4°C. The supernatants were used for the assay.
Assay for urinary L-Trp/kynurenine/Nam metabolites. The daily urinary excretion (nmol/24 h) of anthranilic acid was measured using the HPLC method of Shibata and Onodera (28) . The daily urinary excretions (nmol/24 h) of kynurenine and kynurenic acid (KA) were measured using the methods of Holmes (29) and Shibata (30) . The daily urinary excretions (nmol/24 h) of xanthurenic acid (XA) and 3-hydroxyanthranilic acid (3-HA) were simultaneously measured using the method of Shibata and Onodera (31) . The daily urinary excretion (nmol/24 h) of QA was measured using the method of Mawatari et al. (32) . The daily urinary excretion (nmol/24 h) of Nam, N 1 -methyl-2-pyridone-5-carboxamide (2-Py), and N 1 -methyl-4-pyridone-3-carboxamide (4-Py) was simultaneously measured using the HPLC method of Shibata et al. (33) . The daily urinary excretion (nmol/24 h) of Nam N-oxide was measured using the method of Shibata (34) . The daily urinary excretion (nmol/24 h) of N 1 -methylnicotinamide (MNA) was measured using the method of Shibata (35) . 
Expt. 2
Male C57BL/6 mice (7 wk old) were obtained from Clea Japan. The mice consumed a chemically defined 20% casein diet with preformed niacin (12) and water ad libitum for 1 mo.
The mice were killed by vertebral subluxation. Their organs were dissected and immediately homogenized with a Teflon glass homogenizer in 5 volumes of cold 50 mmol/L KH 2 PO 4 -K 2 HPO 4 buffer, pH 7.0. The resulting homogenates were used as enzyme sources. For measuring the activities of 3-HA-3,4-dioxygenase (3-HAO) and QPRT, homogenates were centrifuged at 20,000 3 g for 20 min at 4°C and the resulting supernatants were used. The methods for measuring enzyme activities involved with the Trp/Nam pathway were previously described (36) . These include TDO (EC 1.13.11.11), kynureninase (EC 3.7.1.3), kynurenine aminotransferase (KAT) (EC 2.6.1.7), 3-HAO (EC 1.13.11.6), QPRT (EC 2.4.2.19), Nam mononucleotide adenylyltransferase (EC 2.7.7.1), Nam methyltransferase (EC 2.1.1.1), 2-Py-forming N 1 -methylnicotinamide oxidase (EC 1.2.3.1), and 4-Py-forming N 1 -methylnicotinamide oxidase (EC number not determined). Each liver was separately homogenized and each enzyme activity was measured separately. The activity values were expressed as mean 6 SEM, n = 5. Others tissues were in such small amounts that each tissue (n = 5) was pooled. The pooled tissues were homogenized and each enzyme activity was measured using the pooled homogenates. The values were expressed as the mean.
Statistical analysis. The values in the tables are expressed as mean 6 SEM. Data were assessed with the Kolmogorov-Smirnov test to examine the distribution type; if data did not exhibit a normal distribution, they were logarithmically transformed prior to analysis. The main effects of genotype and diet were analyzed using a 2-way ANOVA, followed by the Bonferroni post hoc test. When the 2-way ANOVA indicated the presence of a genotype-diet interaction, 1-way ANOVA was conducted followed by TukeyÕs multiple-comparison test among the groups ( Tables  1 and 2 ). StudentÕs t test was performed for comparison between tdo 2/2 and WT mice in the NiA-free diet groups ( Table 3) . Differences of P < 0.05 were considered significant. Graph Pad Prism version 5.0 (Graph Pad Software) was used for all analyses.
Results
Body weight and food intake. Body weight and food intake did not differ among the groups (WT and tdo 2/2 mice fed the complete diet or the NiA-free diet for 1 mo) ( Table 1) .
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Nam and NAD concentrations. The blood total Nam and NAD concentrations did not differ between the tdo 2/2 and WT mice when they were fed the complete diet (Table 1) . However, the blood total Nam concentration was ;50% lower in the tdo 2/ 2 mice fed the NiA-free diet than in the WT mice fed the same diet. The blood NAD concentration was ;35% lower in the tdo 2/ 2 mice than in the WT mice when they were fed the NiA-free diet.
The liver total Nam and NAD concentrations did not differ between the tdo 2/2 and WT mice even when they were fed the complete diet.
TDO activity and L-Trp concentrations. There were no differences in any of these variables between the 2 dietary groups within the mice of the same genotype ( Table 1) . As was predicted, no TDO activity was detected in tdo 2/2 mice. Plasma and liver L-Trp concentrations were ;15-and 20-fold higher in the tdo 2/2 mice than in the WT mice.
Urinary L-Trp/kynurenine/Nam metabolites. The urinary excretion amounts of L-Trp/kynurenine/Nam metabolites are shown in Table 2 . Urinary excretion of unmetabolized L-Trp was ;10-fold higher in the tdo 2/2 mice than in the WT mice. In the tdo 2/2 mice, 10.4 6 2.3% of the ingested L-Trp was eliminated in the urine, whereas in the WT mice it was only 0.6 6 0.2%. The urinary excretion amounts of kynurenine, KA, XA, and 3-HA were higher in the tdo 2/2 mice than in the WT mice regardless of the diet. Conversely, the urinary excretion amounts of QA, and the downstream metabolites such as Nam, Nam N-oxide, MNA, 2-Py, and 4-Py were lower in the tdo 2/2 mice than in the WT mice regardless of the diet. When fed the NiA-free diet, the urinary concentrations of the upstream metabolites kynurenine (320% increase), KA (270% increase), XA (770% increase), and 3-HA (450% increase) were higher in the tdo 2/2 mice than in the WT mice, whereas the urinary concentrations of the downstream metabolite QA (50% less) and the sum of Nam and its catabolites (10% less) were lower in the tdo 2/2 mice than in the WT mice. The urinary excretions of the metabolites of L-Trp to 3-HA were higher, whereas those of QA to Nam and its catabolites were lower in the tdo 2/2 than in the WT mice. Conversion ratios. The conversion ratios from L-Trp to each of the L-Trp metabolites were determined in the mice fed the NiA-free diet to exclude the effect of the preformed niacin intake (Table 3) . Tdo deficiency increased the conversion ratios of L-Trp to kynurenine (200% increase), KA (240% increase), XA (550% increase), and 3-HA (500% increase), whereas it decreased the conversion ratios to QA (50% less) and the downstream metabolites such as Nam (1% less), Nam N-oxide (10% less), MNA (10% less), 2-Py (10% less), and 4-Py (10% less). The conversion ratio of L-Trp to Nam was substantially reduced in tdo 2/2 mice compared with the WT mice (10% less).
Tissue distribution of the enzymes. The activity of the formation of kynurenine from L-Trp, which is the combined activities of TDO and IDO, was detected in several tissues (Supplemental Table 1 ). The activities of L-Trp/Kyn were detected in the small intestine, testis, and muscle. Kynureninase activity was mainly detected in liver and somewhat in spleen, kidney, and small intestine. KAT activity was detected in liver and kidney and the activity in terms of grams of tissue (mol Á h 21 Á g liver 21 or mol Á h 21 Á g kidney 21 ) was higher in kidney than in liver. The activity of 3-HAO was detected in liver and kidney and was extremely high (;1000-fold higher) compared with the other enzymes involved in L-Trp metabolism. QPRT activity was detected in liver and kidney. Nam mononucleotide adenylyltransferase activity, which catalyzes the reaction of Nam mononucleotide + ATP / NAD + inorganic pyrophosphate, was detected in all examined tissues.
The tissue distribution of enzymes involved in Nam catabolism is shown in Supplemental Table 2 . Nam methyltransferase, which catalyzes the reaction of Nam and S-adenosylmethionine / MNA, was detected in liver and lung. The activity of 2-Py forming MNA oxidase was fairly widely detected, but that of 4-Py forming MNA oxidase was limited; the major tissue was liver.
Fate of L-Trp in tdo
2/2 mice. The schematic representation of the fate of L-Trp in tdo 2/2 mice fed the NiA-free diet is shown in Figure 1 . This figure was derived from the data in Table 2,   Supplemental Tables 1 and 2 , and the reported tissue distribution of the enzymes related to the biosynthesis of NAD in rats (37) .
Discussion
The 2 enzymes involved in the initial step of the L-Trp degradation pathway are TDO and IDO. TDO is the key enzyme for the L-Trp/kynurenine/acetyl CoA and LTrp/kynurenine/Nam pathways in liver and it has been reported that knockout of tdo in mice resulted in increased blood Trp concentration (23) . It can be speculated that IDO does not sufficiently compensate for the TDO depletion-dependent blockade of the reaction of L-Trp to N-formylkynurenine from the point of the accumulation of L-Trp in the blood. In the Dietary L-Trp is absorbed by the small intestine and transported into the blood, after which it is distributed to the liver and extrahepatic tissues. The liver is the main site for L-Trp degradation in WT mice. As the tdo 2/2 mice cannot metabolize L-Trp, any L-Trp transported to the liver is returned to the blood and eliminated through the urine. However, L-Trp can be metabolized into N-FK by IDO and then into Kyn by formydase in extrahepatic tissues. The levels of enzymes required for Kyn metabolism in extrahepatic tissues may be so low that the accumulated Kyn is mainly delivered to the blood and urine. Part of the circulating Kyn is transported into the liver, where it is metabolized into Nam via NAD. The Nam synthesized in the liver is distributed to various extrahepatic tissues via the blood. Surplus Nam is catabolized to Nam N-oxide, MNA, 2-Py, and 4-Py in the liver, which are subsequently eliminated through the urine. ACMS, a-aminob-carboxymuconate-e-semialdehyde; AnA, anthranilic acid; N-FK, N-formylkynurenine; IDO, indoleamine-2,3-dioxygenase; Kyn, kynurenine; MNA, N 1 -methylnicotinamide; NaAD, nicotinic acid adenine dinucleotide; NAD, nicotinamide adenine dinucleotide; Nam, nicotinamide; NaMN, nicotinic acid mononucleotide; NMN, nicotinamide mononucleotide; TDO, L-tryptophan-2,3-dioxygenase; tdo 2/2 , tdo knockout; WT, wild type; 2-Py, N present study, we show that in contrast to the blood concentrations of L-Trp, IDO plays a crucial role in the L-Trp/kynurenine/Nam pathway and thus in the synthesis of the minimum necessary amount of Nam to sustain optimum growth in tdo 2/2 mice fed an NiA-free diet. We have already reported that feeding the NiA-free diet to QPRT-knockout mice caused niacin deficiency (12) . TDO activity in the liver of tdo 2/2 mice was below the level of detection and the L-Trp concentrations in the liver, plasma, and urine were >10 times higher in the tdo 2/2 mice than in the WT mice, as previously reported (23) . Surprisingly, body weight, food intake, and liver Nam and NAD concentrations did not differ between the tdo 2/2 and WT mice, even when fed the NiAfree diet. The present data indicate that, at least for 1 mo, niacin deficiency did not occur in the tdo 2/2 mice fed the NiA-free diet. These findings show that the tdo 2/2 mice can synthesize from ingested L-Trp the minimum necessary amount of niacin required for optimum growth. This suggests that IDO, which exists in extrahepatic tissues, participates in the synthesis of Nam from L-Trp in the liver when TDO in the liver is absent for a certain period.
The 10-fold higher urinary excretion of unmetabolized L-Trp in tdo 2/2 mice compared with WT mice, regardless of the type of diet, indicates that TDO, but not IDO, is the major initial enzyme in the systemic L-Trp degradation pathway. Nevertheless, the urinary excretion of kynurenine was ;3-fold higher in the tdo 2/2 mice than in the WT mice, indicating that the activity of IDO as an initial enzyme in L-Trp degradation cannot be ignored in systemic metabolic enzyme. The higher urinary excretion of kynurenine in the tdo 2/2 mice suggests that the expression of IDO may be upregulated when TDO is absent. If a lot of the kynurenine formed in extrahepatic tissues is efficiently transported into the liver, higher urinary excretion of kynurenine and lower urinary excretion of QA and Nam would not occur, because the liver has a high ability to metabolize a high amount of kynurenine into Nam and its catabolites. The urinary excretion levels of KA and XA, which are by-products, were higher in the tdo 2/2 mice than in the WT mice. The reactions of kynurenine / KA and 3-hydroxykynurenine / XA, which are catalyzed by KAT, would be more active in extrahepatic tissues than in liver. In fact, the KAT activity was higher in kidney than in liver.
We think that NAD cannot be synthesized from L-Trp without the liver, because enzymes such as 3-HAO and QPRT are absent in extrahepatic tissues. However, rats (38) and probably mice can live forever even with a diet without preformed niacin, because the Nam formed in the liver is well distributed into extrahepatic tissues. Hence, the concentration of the free type of Nam is a very useful indicator of the available Nam.
The urinary concentrations of Nam and its catabolites, which are highly sensitive niacin nutrient biomarkers in mammals, including humans (39) (40) (41) (42) (43) (44) (45) , were very close to the lower detection limit in the tdo 2/2 mice fed the NiA-free diet. These data indicate that TDO plays a crucial role in the systemic supply of Nam. Nevertheless, the urinary excretion levels of the upper metabolites of the L-Trp/kynurenine/Nam pathway were higher in the tdo 2/2 mice than in the WT mice. These data conflict with the data showing low urinary excretion levels of Nam and its catabolites. Takikawa et al. (46) reported an increase in urinary XA after IDO activation treatment. In the present study, the urinary excretion of XA was higher in the tdo 2/2 mice than in the WT mice. Thus, the absence of TDO may upregulate IDO expression. We thought, however, that the formed kynurenine cannot be well metabolized up to Nam via QA in extrahepatic tissues, because the urinary excretion levels of kynurenine, KA, and XA were much higher in the tdo 2/2 mice than in the WT mice, whereas those of QA and Nam and its metabolites were much lower in the tdo 2/2 mice than in the WT mice. The data obtained from the urine excretion pattern in the tdo 2/2 mice imply that the tissue distribution of 3-HAO, which is the QA-forming enzyme, plays a crucial role in the conversion of L-Trp to Nam in organ-organ interactions. The activity of 3-HAO was detected mainly in liver and slightly in kidney, whereas it was not detected in other tissues. The activity of 3-HAO was ;1000-fold higher compared with the other enzymes involved in the L-Trp/kynurenine/Nam pathway. Therefore, we think that this enzyme is not the limiting enzyme; hence, it does not play an important role in the pathway. However, we propose that liver 3-HAO has an important role in the conversion of L-Trp/QA in the liver, the systemic L-Trp degradation, and the systemic supply of Nam. The findings indicate that when TDO is absent, the rate-limiting step is the reaction of 3-HA/QA, which is catalyzed by 3-HAO in organorgan interactions.
In conclusion, the amount of niacin required for optimum growth in growing mice can be synthesized from L-Trp without TDO for 1 mo. IDO might be responsible not only to the role of the immune system but also for supplying the Nam to the whole body.
